宣布“暂停向中国供应”,美制药巨头回应

南方都市报
06 Feb

近日,默沙东宣布,从2025年2月开始,暂停向中国市场供应HPV疫苗,引发讨论。默沙东回应称,这属于阶段性调整中国市场的发货节奏,预计于年中逐步恢复常态。HPV疫苗分为二价、四价和九价不同类型,价数越高可预防的病毒亚型越广。目前国内已上市的HPV疫苗中,四价疫苗(佳达修)和九价疫苗(佳达修—9)均由默沙东供应。暂停供应后,是否影响疫苗接种?记者联系了广州市多家社区卫生服务中心及公立医院,工作人员均...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10